LUM and melanoma: Lumican derived peptides–lumcorin, have been tested against melanoma and show therapeutic potential by inhibiting cell chemotaxis and melanoma growth through MMP-14 inhibition (Zeltz et al., 2009; Pietraszek et al., 2013).